Alembic Pharmaceuticals is reportedly planning to increase its annual product filings for regulated markets from 7 now to 30 within two years. The Vadodara-based company has increased the number of its projects for product development from 40 in 2013-14 to 200 now. The projects are largely to develop products in injectables and dermatology. These include its own, partnered, and in-licensed products.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.
